Patent · US Active

Compounds

US7700768B2 · kind B2 · utility

1Cited by
32References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 11, 2007
Grant dateApr 20, 2010
Priority date—
Expiry dateNov 25, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel substituted pyrimido[4,5-d]pyrimidin-2-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.